AnandPathakMDPhD, MPH
Preventive Medicine • Silver Spring, MDPublic Health & General Preventive Medicine
Medical Officer, FDA
Dr. Pathak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Blvd
Silver Spring, MD 20993Phone+1 513-313-8620
Summary
- Visionary thought leader in molecular diagnostics for precision oncology and cutting edge molecular diagnostics cancer screening.
Education & Training
University of Michigan School of Public HealthResidency, Public Health and General Preventive Medicine, 2010 - 2012
Jewish Hospital of CincinnatiResidency, Internal Medicine, 2008 - 2009
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2007 - 2008
University of Cincinnati College of MedicineClass of 2007
Certifications & Licensure
MI State Medical License 2012 - 2025- American Board of Preventive Medicine Public Health & General Preventive Medicine
Awards, Honors, & Recognition
- University of Michigan Phi Kappa Phi Phi Kappa Phi
Publications & Presentations
PubMed
- 18 citationsRegulatory implications of ctDNA in immuno-oncology for solid tumors.Paz J Vellanki, Soma Ghosh, Anand Pathak, Michael J Fusco, Erik W Bloomquist
Journal for Immunotherapy of Cancer. 2023-02-01 - 77 citationsFDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.Preeti Narayan, Tatiana M. Prowell, Jennifer J Gao, Laura L. Fernandes, Emily Li
Clinical Cancer Research. 2021-04-01 - 101 citationsFDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, Tara Berman, Preeti Narayan
The Oncologist. 2021-01-01
Press Mentions
50% of Children with Cancer Are Left Undiagnosed and Untreated: StudyMarch 6th, 2019
Public Workshop - Next Generation Sequencing-Based Oncology Panels, February 25, 2016February 25th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
